full
border
#666666
http://www.lennonsearch.com/wp-content/themes/smartbox-installable/
http://www.lennonsearch.com/
#26ADE4
style3
Over 25 Years Of Expertise
828-403-6096

Archive for January, 2014

31
Jan

Amgen is batting 1.000 in its ambitious clinical program for the promising PCSK9 cholesterol drug evolocumab (AMG-145), unveiling a 5th successful Phase III study as it prepares for an FDA application that could give it first-mover status in a blockbuster field. …read more Source: Amgen outpaces its rivals in the race for a PCSK9 blockbuster […]

30
Jan

Eli Lilly has won exactly one new drug approval since 2009, running up an innovation debt that is rapidly catching up to its revenue. But CEO John Lechleiter believes the company’s late-stage pipeline can change what has become a tired narrative. …read more Source: Despite a years-long dry run, Lilly keeps the faith in its […]

29
Jan

Two patients died of sepsis in a Phase II trial of Progenics Pharmaceuticals’ in-development prostate cancer treatment, spurring concern that the drug is too toxic to merit further study and sending the biotech’s shares down as much as 30%. …read more Source: Progenics tanks after two trial deaths cast doubt on its lead program     

default
Loading posts...
link_magnifier
#5C5C5C
off
fadeInDown
loading
#5C5C5C
off